Peter Blackburn
21Patents
12h-index
12Co-inventors
78Inventor score
Filing activity: Mar 1, 1989 → Sep 6, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5304540A | Pharmaceutical bacteriocin compositions and methods for using the same | Emerging Cross-Sectional Technologies | 74 | Expired |
| US5217950A | Nisin compositions for use as enhanced, broad range bactericides | Human Necessities | 61 | Expired |
| US5135910A | Nisin compositions for use as enhanced, broad range bactericides | Human Necessities | 51 | Expired |
| US5260271A | Nisin compositions for use as enhanced broad range bactericides | Human Necessities | 46 | Expired |
| US4980163A | Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection | Emerging Cross-Sectional Technologies | 38 | Expired |
| US5762948A | Moist bacteriocin disinfectant wipes and methods of using the same | Human Necessities | 34 | Expired |
| US5763395A | Stabilized lanthionine bacteriocin compositions | Human Necessities | 31 | Expired |
| US5760026A | Method for treating mastitis and other staphylococcal infections | Chemistry; Metallurgy | 23 | Expired |
| US5334582A | Pharmaceutical bacteriocin compositions and methods for using the same | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5858962A | Composition for treating mastitis and other staphylococcal infections | Chemistry; Metallurgy | 16 | Expired |
| US5804549A | Compositions with activity against helicobacter | Human Necessities | 13 | Expired |
| US5753614A | Nisin compositions for use as enhanced, broad range bactericides | Human Necessities | 13 | Expired |
| US5866539A | Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection | Human Necessities | 8 | Expired |
| US5691301A | Nisin compositions for use as enhanced, broad range bactericides | Human Necessities | 6 | Expired |
| US9498522B2 | Immunotherapeutic compositions for the treatment of alzheimer'S disease | Emerging Cross-Sectional Technologies | 3 | Active |
| US11419924B2 | Immunotherapeutic compositions for the treatment of Alzheimer's disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US12370251B2 | Adjuvanted nanoparticulate influenza vaccine | Chemistry; Metallurgy | 0 | Active |
| US11110155B2 | Immunotherapeutic compositions for the treatment of Alzheimer's disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US10515146B2 | Multi-template kit system and process | Physics | 0 | Active |
| US10335468B2 | Immunotherapeutic compositions for the treatment of alzheimer's disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US10716836B2 | Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.